MABVAX

Welcome to the Brand page for “MABVAX”, which is offered here for Radiopharmaceutical imaging and detection agents developed using monoclonal antibodies for diagnosing and monitoring cancer; diagnostic kits consisting primarily of monoclonal antibodies, and reagents for use in disease testing; therapeutic pharmaceuticals developed using monoclonal antibodies for the treatment of cancer and other malignancies;.

Its status is currently believed to be active. Its class is unavailable. “MABVAX” is believed to be currently owned by “MabVax Therapeutics, Inc.”


Owner:
MABVAX THERAPEUTICS, INC.
Owner Details
Description:
Radiopharmaceutical imaging and detection agents developed using monoclonal antibodies for diagnosing and monitoring cancer; Diagnostic kits consisting primarily of monoclonal antibodies, and reagents for use in disease testing; Therapeutic pharmaceuticals developed using monoclonal antibodies for the treatment of cancer and other malignancies;
Categories: RADIOPHARMACEUTICAL IMAGING DETECTION AGENTS